Dentists from around the world to learn about the innovative and life-changing treatments for patients suffering from obstructive sleep apnea and snoring
HIGHLANDS RANCH, Colo., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (OSA) and snoring, today announced the commencement of the 3rd-annual Breathing Wellness Conference presented by The Vivos Institute, which will take place from October 20-23, 2021, at Caesars Palace in Las Vegas, Nevada.
Dentists and medical doctors from around the world will hear from the industry’s top experts on OSA about its impact on chronic conditions such as heart disease, chronic fatigue, and dementia. Attendees will also have the opportunity learn how innovations supporting the science of dentofacial sleep medicine are transforming the future of dentistry forever.
“Dentists are essential to solving the sleep and breathing epidemic as they serve as the front line to proper screening, education, and increasingly, treatment. Our annual Breathing Wellness Conference gives us a chance to educate these individuals on the dangers of OSA and share more about the latest innovations in treatment as we seek to improve the oral and overall health of patients,” said Kirk Huntsman, CEO, Vivos. “Rather than patch OSA with temporary, invasive solutions like CPAP machines and surgery, dentists are leading the change and focusing on potentially life-changing treatments that address the root cause of OSA.”
Dentists and other doctors appearing at the Breathing Wellness Conference as guest speakers include:
Mimi Guarneri, MD: Sleep-Disordered Breathing: A Reversible Cardiovascular Risk Factor
Dave Singh, DMD, PhD, DDSc: Introduction to Craniofacial Sleep Medicine
Ben Miraglia, DDS: How Did We Get Here – Origins of Sleep-Disordered Breathing and Sleep Apnea
Jon Caulfield, DDS: The Paradigm Shift – Looking Beyond the Mouth
Jerry Hu, DDS: My Personal Journey
Kalli Hale, DDS: Don’t Roll the Dice on Your Airway
Sahil Chopra, MD: Interpreting Home Sleep Tests
Matthew Walker, PhD: Why Sleep?
Chris Farrugia, DDS: Medical Billing in the Dental Practice
For more information about the 2021 Annual Breathing Wellness Conference Presented by The Vivos Institute click here: https://thevivosinstitute.com/breathing-wellness-conference-2021/.
Located in Denver, Colorado, the 15,000-square-foot Vivos Institute was established by Vivos Therapeutics, Inc. to provide advanced post-graduate education and training to dentists, dental teams and other healthcare providers from around the world in a live and hands-on setting. The Institute’s emphasis is on educating healthcare providers about OSA and Vivos’ treatments for OSA within their practice areas, along with training on Vivos’ related practice management tools for dentists.
Vivos Therapeutics Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for adult patients suffering from mild-to-moderate obstructive sleep apnea (OSA). The Vivos treatment involves customized oral appliances and treatment protocols called the Vivos System. Vivos believes that its Vivos System oral appliance technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for adults with mild-to-moderate OSA. Vivos also sells orthodontic appliances for adults and children. Vivos’ oral appliances have proven effective in over 19,000 patients treated worldwide by more than 1,250 trained dentists.
Combining proprietary technologies and protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway, the Vivos System opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes VivosScore, powered by the SleepImage diagnostic technology, for Home Sleep Testing in adults and children. The Vivos Integrated Practice (VIP) program offers dentists training and other value-added services in connection with using the Vivos System.
Cautionary Note Regarding Forward-Looking Statements
This press release and statements of the Company’s management made in connection therewith contain “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events, particularly with respect to the public offering described herein. Words such as “aim”, “may”, “could”, “expects”, “projects,” “intends”, “plans”, “believes”, “predicts”, “anticipates”, “hopes”, “estimates” and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks and are based upon several assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond Vivos’ control. Actual results (including the anticipated benefits of the Company’s Breathing Wellness Conference as described herein) may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the risk factors described in Vivos’ filings with the Securities and Exchange Commission (“SEC”). Vivos’ filings can be obtained free of charge on the SEC's website at www.sec.gov. Except to the extent required by law, Vivos expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Vivos' expectations with respect thereto or any change in events, conditions, or circumstances on which any statement is based.
Vivos Investor Relations Contact: Edward Loew Investor Relations Officer (602) 903-0095 ed@vivoslife.com
Vivos Media Relations Contact: Joe McIntyre / Jenny Robles KCSA Strategic Communications (856) 381-8996 / (212) 896-1231 jmcintyre@kcsa.com / jrobles@kcsa.com
Wood believes we're still in a strong bull market. Take advantage.
EV stocks are being dumped as a group today, even with these three names reporting good news recently.
More than 90 large-cap stocks are down at least 20% from their 2021 highs, but analysts love many of them, including JD.com, PayPal and Disney.
Buffett is taking profits off the table. It might be time to do the opposite.
Losing money in the S&P 500 is never fun. But it stings all the more when everyone else is making tons on their stocks.
A cosmetics and skin care products company founded by married Taiwanese actors Zhang Ting and Lin Ruiyang has had assets worth 600 million yuan (US$94 million) frozen due to an investigation by China's market regulator over an alleged pyramid scheme. The market regulator in Shijiazhuang, the capital of northern China's Hebei province, said it had received several reports about a suspected pyramid scheme involving Shanghai Dowell Trading, according to a letter widely circulated on Chinese social
Get aboard the Tesla stock train, argues Dan Ives at Wedbush.
The American Idol alum defended her husband from backlash on Instagram, writing, "Stop being so offended by what people post who have zero impact on your life and move on"
The stock has already managed to settle below the $115 level and is moving towards yearly lows at $108.70.
Time's almost up on ultra-low rates, so don't be caught off guard.
Yahoo Finance Live's Jared Blikre examines the latest market action, in addition to reporting on Biogen undergoing acquisition negotiations by Samsung
Question: I’m now 39, and in a better place in my life than I was roughly 10 years ago, when I decided to take out over $100,000 in student loans to attend a food policy and nutrition master’s program. The program was the only master’s program I got into, and I didn’t care what the cost was — I didn’t even look at what I was signing. The loan payments are too expensive, even though I’m now a nutrition and public health consultant who works on a contractual basis, and I make a good salary — $110,000 a year.
What happened Shares of Ocugen (NASDAQ: OCGN) were falling 5.1% as of 12:03 p.m. ET on Wednesday. The company hasn't made any announcements this week. Its stock appears to simply be continuing a slide that began in early November.
The rally in Victoria's Secret may just be getting started, contends JP Morgan retail analyst Matt Boss.
(Bloomberg) -- Didi Global Inc. disclosed a $4.7 billion loss after revenues shrank in the September quarter, revealing the rising cost of a series of regulatory actions that will force China’s ride-sharing leader to shift its listing to Hong Kong next year.Most Read from BloombergGhislaine Maxwell Found Guilty in Win for Epstein VictimsMercedes Swept Up in China Internet Furor Over Models’ EyesApple Aims to Prevent Defections to Meta With Rare $180,000 Bonuses for Top TalentThe Senator Who Coul
The need of a robust charging infrastructure to support the growth of electric vehicles (EVs) is undisputed. What isn't as clear is which players will be instrumental in developing this infrastructure and, more importantly, whether can they do this profitably. Let's discuss which of the two top EV charging stocks, ChargePoint (NYSE: CHPT) and Blink Charging (NASDAQ: BLNK), is a better buy right now.
If you want to leave some stocks to your heirs, then you'll want to find companies like these that are poised to thrive for decades to come.
Several factors can shrink your monthly Social Security benefits payment. Here are three of the most common.
What happened Shares of Novavax (NASDAQ: NVAX) were slipping 2.6% lower as of 11:35 a.m. ET on Wednesday. The company didn't report any new developments since yesterday's announcement that India had granted Emergency Use Authorization (EUA) to COVID-19 vaccine NVX-CoV2373.
For the second day in a row, shares of electric truck start-up Rivian (NASDAQ: RIVN) are rolling downhill. Down 5.4% as of 11:40 a.m. ET on Wednesday, the speed of Rivian stock's slide seems to be accelerating since yesterday. In a midday story yesterday, the electric cars news site reported on an email sent out by Rivian CEO RJ Scaringe to Rivian customers who had ordered "Adventure and Explore Package" models of R1T electric pickup trucks and R1T electric SUVs.